Details
| Stereochemistry | MIXED |
| Molecular Formula | C20H24N2O5.ClH |
| Molecular Weight | 408.876 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CCC1=CC2=C(OCO2)C=C1)NCC(O)C3=CC(C(N)=O)=C(O)C=C3
InChI
InChIKey=YYWISFWLJSVFOF-UHFFFAOYSA-N
InChI=1S/C20H24N2O5.ClH/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25;/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25);1H
Medroxalol is a competitive antagonist at alpha1-adrenergic receptors and beta1-adrenergic receptors. Medroxalol also an agonist at beta2-adrenergic receptors. Medroxalol exerts antihypertensive and vasodilating effects. It was concluded that the principal action of medroxalol was to produce a fall in blood pressure by decreasing peripheral vascular resistance more than cardiac output.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Antihypertensive and vasodilating effects of acute medroxalol, a new beta-blocker with beta-2-adrenergic receptor stimulation. | 1986-07-01 |
|
| Analysis of the hypotensive effects of medroxalol and its enantiomers, MDL 17,330A and MDL 17,331A. | 1984 |
|
| Cardiovascular properties of medroxalol, a new antihypertensive drug. | 1981-03-01 |
|
| Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol. | 1980-12-22 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
274-347-3
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
198526
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
313453
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL113278
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
70161-10-3
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
300000055247
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
X0041CUE0M
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY | |||
|
C170156
Created by
admin on Mon Mar 31 17:53:58 GMT 2025 , Edited by admin on Mon Mar 31 17:53:58 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD